Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs DAR✓SelectedUSD · DARGSK vs DAR performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs DAR

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+97.1%
DAR return
+271.1%
Excess return
-174.1%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioDARExcessAlpha
1D-0.1%-2.7%+2.5%+0.2%
7D-5.3%-9.6%+4.3%-4.3%
30D-3.7%-14.3%+10.7%-2.2%
3M-7.3%-25.4%+18.1%-4.6%
6M-4.2%-14.2%+9.9%-3.2%
YTD+0.9%+40.6%-39.7%-4.1%
1Y+7.3%+57.5%-50.3%+0.6%
3Y+52.7%+16.3%+36.4%+45.4%
5Y+40.1%-29.1%+69.3%+39.8%
All+97.1%+271.1%-174.1%+41.8%

Cumulative growth

Daily Returns

Daily percentage return beside DAR.

Daily Out/Under-Performance

Portfolio return minus DAR return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × DAR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded DAR wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling